Gynaecology

Titus Health Care is founded on two important commercial pillars: Contraception and Fertility.

By means of a an extensive network and experience in gynaecology, Titus Health Care is actively seeking to introduce new gynaecological products and devices that will bring added value for Dutch women.

Contraception

Titus Health Care is the distributor of the hormone-free T-Safe® contraceptive intra-uterine device, the only IUD that is registered as reliable for 10 years and the most effective copper IUD on the market. THC is also the distributor of the Multi-Safe® CU 375 and the Multi-Safe® short contraceptive IUD for women with a small uterus. More information.

Fertility

Bemfola® (follitropin alfa) is indicated for anovulation or for the stimulation of multi-follicular development in women undergoing fertility treatments such as IVF and ICSI. In addition, an IVF prediction test is being developed by sister company ARTPred in collaboration with the Erasmus MC and the VU Amsterdam. This involves a test (ReceptIVFity) wich is able to predict for which women IVF will not result in a pregnancy, based on the microbiome composition of the female urine and vaginal fluid. With this new test, women can avoid the disappointment of failed fertility treatments.

Bemfola® (follitropin alfa) is indicated for anovulation or for the stimulation of multi-follicular development in women undergoing fertility treatments such as IVF and ICSI. In addition, an IVF prediction test is being developed by sister company ARTPred in collaboration with the Erasmus MC and the VU Amsterdam. This involves a test (ReceptIVFity) wich is able to predict for which women IVF will not result in a pregnancy, based on the microbiome composition of the female urine and vaginal fluid. With this new test, women can avoid the disappointment of failed fertility treatments. More information.